The need for evolution in healthcare decision modeling

Medical Care

Volumn 41, Issue 9, 2003, Pages 1024-1033

  Lee, Robert C ^a,c   Donaldson, C A M ^a,b   Cook, Linda S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

Decision analysis; Hormonal therapy; Uncertainty analysis; Utility analysis; Women's health

Indexed keywords

ARTICLE; DECISION MAKING; DECISION SUPPORT SYSTEM; ESTROGEN THERAPY; FEMALE; HEALTH SERVICES RESEARCH; HUMAN; RISK FACTOR; UNCERTAINTY; WOMEN'S HEALTH;

DECISION MAKING; DECISION SUPPORT TECHNIQUES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; RISK FACTORS; UNCERTAINTY; WOMEN'S HEALTH;

EID: 0141653923     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MLR.0000083746.54410.CF     Document Type: Article

References (69)

1. Clemen RT. Making Hard Decisions, 2nd ed. Pacific Grove, CA: Duxbury; 1996.
2. Dowie J. Evidence based medicine. Needs to be within framework of decision making based on decision analysis. BMJ 1996;313:170-171.
3. Raiffa H. Decision Analysis: Introductory Lectures on Choices Under Uncertainty, 1st ed. Reading, MA: Addison-Wesley; 1968.
4. Keeney RL. Value-Focused Thinking: A Rath to Creative Decisionmaking, 1st ed. Boston: Harvard University Press; 1992.
5. Haimes YY. Risk Modeling, Assessment, and Management, 1st ed. New York John Wiley & Sons; 1998.
6. Sculpher M, Fenwick E, Claxton K. Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application. Pharmacoeconomics 2000; 17:461-477.
7. Dolan JG. A survey of clinicians'opinions regarding the value of published decision analyses as sources of clinically useful information. Med Decis Making 1997;17:427-430.
8. Naglie G, Krahn MD, Naimark D, et al. Primer on medical decision analysis: Part 3 - estimating probabilities and utilities. Med Decis Making 1997;17:136-141.
9. Detsky AS, Naglie G, Krahn MD, et al. Primer on medical decision analysis: Part 2-building a tree. Med Decis Making 1997;17:126-135.
10. Detsky AS, Naglie G, Krahn MD, et al. Primer on medical decision analysis: Part 1 - getting started. Med Decis Making 1997;17:123-125.
11. Stinnett AA, Paltiel AD. Mathematical programming for the efficient allocation of health care resources. J Health Econ 1996;15:641-653.
12. Phillips LD. Requisite decision modeling. J Operat Res Soc 1982;33:303-312.
13. Harper G, Townsend J, Buxton M. The preliminary economic evaluation of health technologies for the prioritization of health technology assessments. A discussion. Int J Technol Assess Health Care 1998;14:652-662.
14. Morgan MG, Henrion M. Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis. Cambridge, UK: Cambridge University Press; 1990.
15. Morgan MG, Fischhoff B, Bostrom A, et al. Risk Communication: A Mental Models Approach, 1st ed. Cambridge, UK: Cambridge University Press; 2002.
16. Nease RF Jr, Owens DK. Use of influence diagrams to structure medical decisions. Med Decis Making 1997;17:263-275.
17. Owens DK, Shachter RD, Nease RF Jr. Representation and analysis of medical decision problems with influence diagrams. Med Decis Making 1997;17:241-262.
18. Cher DJ, Miyamoto J, Lenert LA. Incorporating risk attitude into Markov-process decision models: importance for individual decision making. Med Decis Making 1997;17:340-350.
19. Hazen GB, Hopp WJ, Pellissier JM. Continuous-risk utility assessment in medical decision making. Med Decis Making 1991;11:294-304.
20. O'Brien BJ, Gertsen K, Willan AR, et al. Is there a kink in consumers'threshold value for cost-effectiveness in health care? Health Econ 2002;11:175-180.
21. Spiegelhalter DJ, Freedman LS, Parmar MK. Applying Bayesian ideas in drug development and clinical trials. Stat Med 1993;12:1501-1511.
22. Spiegelhalter DJ, Myles JP, Jones DR, et al. Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ 1999;319:508-512.
23. Spiegelhalter DJ, Myles JP, Jones DR, et al. Bayesian methods in health technology assessment: a review. Health Technol Assess 2000;4:1-130.
24. Claxton K, Neumann PJ, Araki S, et al. Bayesian value-of-information analysis. An application to a policy model of Alzheimer's disease. Int J Technol Assess Health Care 2001;17:38-55.
25. Luce BR, Shih YC, Claxton K. Introduction. Bayesian approaches to technology assessment and decision making. Int J Technol Assess Health Care 2001;17:l-5.
26. Cook LS, Weiss NS. Endometrial Cancer. In: Goldman MB, Hatch MC, eds. Women and Health. San Diego: Academic Press; 1999.
27. Helton JC, Davis FJ. Illustration of sampling-based methods for uncertainty and sensitivity analysis. Risk Anal 2002;22:591-622.
28. Helton JC, Iman RL. Sensitivity analysis of a model for the environmental movement of radionuclides. Health Phys 1982;42:565-584.
29. Felli JC, Hazen GB. Sensitivity analysis and the expected value of perfect information. Med Decis Making 1998;18:95-109.
30. Felli JC, Hazen GB. A Bayesian approach to sensitivity analysis. Health Econ 1999;8:263-268.
31. Hunink M, Glasziou P, Siegel J, et al. Decision Making in Health and Medicine, 1st ed. Cambridge, UK: Cambridge University Press; 2001.
32. International Atomic Energy Agency. Evaluating the Reliability of Predictions Made Using Environmental Transfer Models. Vienna, Austria; 1989.
33. Kakehashi M. A mathematical analysis of the spread of HIV/AIDS in Japan. IMA J Math Appl Med Biol 1998;15:299-311.
34. Cullen AC. The sensitivity of probabilistic risk assessment results to alternative model structures: a case study of municipal waste incineration. J Air Waste Manag Assoc 1995;45:538-546.
35. Seaholm SK, Yang JJ, Ackerman E. Order of response surfaces for representation of a Monte Carlo epidemic model. Int J Biomed Comput 1988;23: 113-123.
36. Claxton K. Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals. Health Econ 1999;8:269-274.
37. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999;18:341-364.
38. Hoffman FO, Hammonds JS. Propagation of uncertainty in risk assessments: the need to distinguish between uncertainty due to lack of knowledge and uncertainty due to variability. Risk Anal 1994;14:707-712.
39. Finkel AM, Evans JS. Evaluating the benefits of uncertainty reduction in environmental health risk management. J Air Poll Control Assoc 1987;37:1164-1171.
40. Rifkin RD. Classical statistical considerations in medical decision models. Med Decis Making 1983;3:197-214.
41. Drummond M, McGuire A. Economic Evaluation in Health Care: Merging Theory with Practice. Oxford, UK: Oxford University Press; 2001.
42. Donaldson C, Birch S, Gafni A. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes. Health Econ 2002;11:55-70.
43. Ubel PA, Nord E, Gold M, et al. Improving value measurement in cost-effectiveness analysis. Med Care 2000;38:892-901.
44. Birch S, Donaldson C. Cost-benefit analysis: dealing with the problems of indivisible projects and fixed budgets. Health Policy 1987;7:61-72.
45. Donaldson C. The (near) equivalence of cost-effectiveness and cost-benefit analyses. Fact or fallacy? Pharmacoeconomics 1998;13:389-396.
46. Ginsber GM, Slater PE, Shouval D. Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity. J Hepatol 2001;34:92-99.
47. French MT, Salome HJ, Sindelar JL, et al. Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI. Health Serv Res 2002;37:433-455.
48. Zhou F, Bisgard KM, Yusuf HR, et al. Impact of Universal Haemophilus influenzae type b vaccination starting at 2 months of age in the united states: an economic analysis. Pediatrics 2002;110:653-661.
49. Spoth RL, Guyll M, Day SX. Universal familyfocused interventions in alcohol-use disorder prevention: cost-effectiveness and cost-benefit analyses of two interventions. J Stud Alcohol 2002;63:219-228.
50. Ogden KW. The effects of paved shoulders on accidents on rural highways. Accid Anal Prev 1997;29:353-362.
51. Griffiths CW, Dockins C, Owens N, et al. What to do at low doses: a bounding approach for economic analysis. Risk Anal 2002;22:679-688.
52. Sassi F, Archard L, Le Grand J. Equity and the economic evaluation of healthcare. Health Technol Assess 2001;5:1-138.
53. Wingo PA, McTiernan A. The risks and benefits of hormone replacement therapy. In: Goldman MB, Hatch MC, eds. Women and Health. San Diego: Academic Press; 1999.
54. Zivin JG. Cost-effectiveness analysis with risk aversion. Health Econ 2001;10:499-508.
55. Cox LA. Risk Analysis: Foundations, Models, and Methods, 1st ed. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001.
56. Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982;30:1043-1069.
57. Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995;7:503-520.
58. Brennan PF, Anthony MK. Measuring nursing practice models using multi-attribute utility theory. Res Nurs Health 2000;23:372-382.
59. Lin WC, Ball C. Factors affecting the decision of nursing students in Taiwan to be vaccinated against hepatitis B infection. J Adv Nurs 1997;25:709-718.
60. Pellissier JM, Venta ER. Introducing patient values into the decision making process for breast cancer screening. Women Health 1996;24:47-67.
61. Vincke P. Multicriteria Decision-Aid. New York: John Wiley & Sons; 1992.
62. Koksalan MU, Sagala PNS. Interactive approaches for discrete alternative multiple criteria decision making with monotone utility functions. Management Science 1995;41:1158-1171.
63. French SA. Decision Theory: An Introduction to the Mathematics of Rationality. Chichester, UK: Ellis-Horwood; 1988.
64. Yu Y. Multiobjective decision theory for computational optimization in radiation therapy. Med Phys 1997;24:1445-1454.
65. Keeney RL. Utility functions for equity and public risk. Management Science 1980;26:345-353.
66. Keeney RL, Winkler RL. Evaluating decision strategies for equity and public risks. Operations Research 2002;33:955-970.
67. Fishburn PC. Equity axioms for public risks. Operations Research 1984;32:901-908.
68. Boiney LG. When efficient is insufficient: fairness in decisions affecting groups. Management Science 1995;41:1523-1537.
69. Grann VR, Jacobson JS, Whang W, et al. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis. Cancer J Sei Am 2000;6:13-20.